跳至主要内容
临床试验/NCT00978575
NCT00978575已完成4 期

Comparison of the Efficacy of Compliant Oral Iron Treatment (FerroDuretter ®) for 3 Months After Discharge Versus Single-dose of Intravenous Iron (Ferinject ®) Before Discharge in Patients With Acute Bleeding From Upper Gastrointestinal Tract. A Double Blinded Randomized Trial

University of Aarhus1 个研究点 分布在 1 个国家目标入组 97 人开始时间: 2010年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
97
试验地点
1
主要终点
haemoglobin

研究概览

简要总结

The trial is a double-blind randomized trial designed to examine whether compliant iron therapy (intravenous or oral) for 3 months after discharge increases hemoglobin levels more and faster than no treatment - in patients with acute bleeding from upper gastrointestinal tract. The trial will include 126 patients at Aarhus University Hospital. In addition to efficacy assessment quality of life assessment and health economic calculations between the treatments will be compared.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Acute upper gastrointestinal bleeding

排除标准

  • Liver disease
  • Terminal cancer
  • Kidney disease
  • variceal bleeding
  • Pregnancy

研究组 & 干预措施

Intravenous iron

Active Comparator

干预措施: ferricarboxymaltose (Drug)

Oral iron

Active Comparator

干预措施: Ferrosulfate (Drug)

Isotonic Sodium and placebo tablets

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

haemoglobin

时间窗: 13 weeks

次要结局

  • Quality of life Health economics(13 weeks, 6 and 12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Palle Bager

Clinical Nurse Specialist, RN, MPH

University of Aarhus

研究点 (1)

Loading locations...

相似试验